Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Connectus Wealth LLC

Connectus Wealth LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 39.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 39,034 shares of the pharmacy operator’s stock after selling 25,347 shares during the period. Connectus Wealth LLC’s holdings in Walgreens Boots Alliance were worth $1,019,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Vanguard Group Inc. lifted its stake in Walgreens Boots Alliance by 14.5% during the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after acquiring an additional 10,962,030 shares during the period. Capital World Investors lifted its stake in shares of Walgreens Boots Alliance by 29.1% in the 4th quarter. Capital World Investors now owns 18,448,648 shares of the pharmacy operator’s stock valued at $481,694,000 after purchasing an additional 4,163,317 shares during the period. Invesco Ltd. lifted its stake in shares of Walgreens Boots Alliance by 21.5% in the 3rd quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after purchasing an additional 3,013,807 shares during the period. Morgan Stanley lifted its stake in shares of Walgreens Boots Alliance by 15.8% in the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after purchasing an additional 1,720,228 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Walgreens Boots Alliance by 10.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,519,845 shares of the pharmacy operator’s stock valued at $170,233,000 after purchasing an additional 613,847 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $15.94 on Tuesday. Walgreens Boots Alliance, Inc. has a 52-week low of $14.62 and a 52-week high of $32.89. The firm has a market capitalization of $13.75 billion, a price-to-earnings ratio of -2.28, a PEG ratio of 0.99 and a beta of 0.78. The company has a fifty day simple moving average of $17.36 and a 200-day simple moving average of $20.76. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same quarter in the prior year, the firm earned $1.16 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 6.27%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is currently -14.29%.

Analyst Upgrades and Downgrades

WBA has been the subject of several analyst reports. UBS Group decreased their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Truist Financial reissued a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Finally, Bank of America cut their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $23.57.

View Our Latest Analysis on WBA

Insider Buying and Selling

In other news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the SEC, which is available through this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.